Matthias Urmann

USPTO Granted Patents = 32 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 21 (Patent Applications = 8)

Average Co-Inventor Count = 6.9

ph-index = 7

Forward Citations = 159(Granted Patents)

Location History:

Eschborn, DE (US) (2007)
Eschborn, DE (2006 - 2011)
Frankfurt-am-Main, DE (2009 - 2015)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

patents

4. 4 out of 207

Aventis Pharmaceuticals Inc.

patents

Years Active: 2006-2015

Loading Chart...

32 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),

2. 8748483 - Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome (2014-06-10),

3. 8735586 - Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles (2014-05-27),

4. 8716317 - Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2014-05-06),

5. 8487109 - Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates (2013-07-16),

6. 8420812 - Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates (2013-04-16),

7. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),

8. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),

9. 8283476 - Transition metal catalyzed synthesis of 2H-indazoles (2012-10-09),

10. 8188282 - Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles (2012-05-29),

11. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),

12. 8088925 - Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors (2012-01-03),

13. 8026375 - Transition metal catalyzed synthesis of N-aminoindoles (2011-09-27),

14. 7910612 - 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use (2011-03-22),

15. 7858647 - N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use (2010-12-28),

Title: Matthias Urmann: Pioneering Inventor from Frankfurt am Main

Introduction: Matthias Urmann is a distinguished inventor hailing from the vibrant city of Frankfurt am Main, Germany. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of patents and inventions.

Latest Patents: Matthias Urmann's latest patents showcase his expertise in cutting-edge technologies, ranging from artificial intelligence to sustainable energy solutions. His innovative ideas continue to shape the future of various industries.

Career Highlights: Throughout his illustrious career, Matthias Urmann has been recognized for his groundbreaking inventions that have revolutionized the way we live and work. His commitment to pushing the boundaries of what is possible has earned him a reputation as a visionary in the world of innovation.

Collaborations: Matthias Urmann has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work seamlessly with diverse teams has led to the successful development and implementation of numerous patented technologies.

Conclusion: In conclusion, Matthias Urmann stands as a true pioneer in the world of inventions, with a remarkable track record of transforming ideas into tangible solutions. His relentless pursuit of innovation continues to inspire the next generation of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.